Longitudinal Anti-müllerian Hormone in Women with Polycystic Ovary Syndrome: an Acupuncture Randomized Clinical Trial

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2012 Sep 12

PMID 22966246

Citations 6

Authors

Jason Franasiak

Steven L Young

Christopher D Williams

Lisa M Pastore

Affiliations

Soon will be listed here.

Abstract

Others have studied acupuncture treatment for polycystic ovary syndrome (PCOS). Anti-müllerian hormone (AMH) is positively correlated with the ovarian follicle pool, thus making it a useful ovarian reserve measure. AMH is elevated in women with PCOS and has been suggested as a diagnostic tool. This study examined the impact of electroacupuncture on AMH concentration in women with PCOS. Seventy-one women with PCOS participated in a randomized, double-blind, sham-controlled clinical trial of acupuncture. Three longitudinal AMH samples over the 5-month protocol were compared with objective ovulation parameters primarily using nonparametric statistics. Results indicated that AMH levels in PCOS were higher than published norms in women without PCOS. There was no difference between the true and sham acupuncture arms in the change in AMH longitudinally. Baseline AMH, but not the change in AMH over time, was inversely correlated with ovulation and menstrual cycle frequencies in both arms combined (P < 0.001). In conclusion, AMH correlated with an increased likelihood of monthly ovulation, as expected from the literature on women without PCOS. The lack of difference by intervention in AMH was consistent with the underlying clinical trial. AMH may be clinically useful to predict which PCOS women are more likely to respond to an intervention.

Citing Articles

Underlying mechanisms of acupuncture therapy on polycystic ovary syndrome: Evidences from animal and clinical studies.

Ye Y, Zhou C, Hu H, Fukuzawa I, Zhang H Front Endocrinol (Lausanne). 2022; 13:1035929.

PMID: 36353235 PMC: 9637827. DOI: 10.3389/fendo.2022.1035929.

Efficacy of a Persian Herbal Remedy and Electroacupuncture on Metabolic Profiles and Anthropometric Parameters in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.

Rouhani M, Motavasselian M, Taghipoor A, Layegh P, Asili J, Hamedi S Galen Med J. 2021; 8:e1389.

PMID: 34466504 PMC: 8344036. DOI: 10.31661/gmj.v8i0.1389.

The Efficacy of Complementary and Alternative Medicine in the Treatment of Female Infertility.

Feng J, Wang J, Zhang Y, Zhang Y, Jia L, Zhang D Evid Based Complement Alternat Med. 2021; 2021:6634309.

PMID: 33986820 PMC: 8093064. DOI: 10.1155/2021/6634309.

Acupuncture for polycystic ovarian syndrome: A systematic review and meta-analysis.

Jo J, Lee Y, Lee H Medicine (Baltimore). 2017; 96(23):e7066.

PMID: 28591042 PMC: 5466220. DOI: 10.1097/MD.0000000000007066.

Acupuncture for treating polycystic ovary syndrome: guidance for future randomized controlled trials.

Wu Y, Robinson N, Hardiman P, Taw M, Zhou J, Wang F J Zhejiang Univ Sci B. 2016; 17(3):169-80.

PMID: 26984837 PMC: 4794508. DOI: 10.1631/jzus.B1500301.

References

Legro R, Finegood D, Dunaif A . A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998; 83(8):2694-8. DOI: 10.1210/jcem.83.8.5054. View

van Rooij I, Broekmans F, Scheffer G, Looman C, Habbema J, de Jong F . Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005; 83(4):979-87. DOI: 10.1016/j.fertnstert.2004.11.029. View

Stankiewicz M, Smith C, Alvino H, Norman R . The use of complementary medicine and therapies by patients attending a reproductive medicine unit in South Australia: a prospective survey. Aust N Z J Obstet Gynaecol. 2007; 47(2):145-9. DOI: 10.1111/j.1479-828X.2007.00702.x. View

Nardo L, Yates A, Roberts S, Pemberton P, Laing I . The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod. 2009; 24(11):2917-23. DOI: 10.1093/humrep/dep225. View

Fallat M, Siow Y, Marra M, Cook C, Carrillo A . Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil Steril. 1997; 67(5):962-5. DOI: 10.1016/s0015-0282(97)81417-3. View

La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S . Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod. 2006; 22(3):766-71. DOI: 10.1093/humrep/del421. View

Norman R, Dewailly D, Legro R, Hickey T . Polycystic ovary syndrome. Lancet. 2007; 370(9588):685-97. DOI: 10.1016/S0140-6736(07)61345-2. View

Pastore L, Williams C, Jenkins J, Patrie J . True and sham acupuncture produced similar frequency of ovulation and improved LH to FSH ratios in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011; 96(10):3143-50. PMC: 3200239. DOI: 10.1210/jc.2011-1126. View

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1):19-25. DOI: 10.1016/j.fertnstert.2003.10.004. View

10.

Park J, White A, Stevinson C, Ernst E, James M . Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med. 2003; 20(4):168-74. DOI: 10.1136/aim.20.4.168. View

11.

Coulson C, Jenkins J . Complementary and alternative medicine utilisation in NHS and private clinic settings: a United Kingdom survey of 400 infertility patients. J Exp Clin Assist Reprod. 2005; 2(1):5. PMC: 1084360. DOI: 10.1186/1743-1050-2-5. View

12.

Steiner A, Herring A, Kesner J, Meadows J, Stanczyk F, Hoberman S . Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol. 2011; 117(4):798-804. PMC: 3825553. DOI: 10.1097/AOG.0b013e3182116bc8. View

13.

Laven J, Mulders A, Visser J, Themmen A, de Jong F, Fauser B . Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004; 89(1):318-23. DOI: 10.1210/jc.2003-030932. View

14.

Lin Y, Chiu W, Wu C, Tzeng C, Hsu C, Hsu M . Antimüllerian hormone and polycystic ovary syndrome. Fertil Steril. 2011; 96(1):230-5. DOI: 10.1016/j.fertnstert.2011.04.003. View

15.

Amer S, Li T, Ledger W . The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy. Hum Reprod. 2009; 24(11):2760-6. DOI: 10.1093/humrep/dep271. View

16.

Silberstein T, MacLaughlin D, Shai I, Trimarchi J, Lambert-Messerlian G, Seifer D . Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod. 2005; 21(1):159-63. DOI: 10.1093/humrep/dei270. View

17.

Smith J, Eisenberg M, Millstein S, Nachtigall R, Shindel A, Wing H . The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States. Fertil Steril. 2010; 93(7):2169-74. PMC: 2860047. DOI: 10.1016/j.fertnstert.2010.02.054. View

18.

Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen J . Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod. 2005; 20(7):1820-6. DOI: 10.1093/humrep/deh850. View

19.

March W, Moore V, Willson K, Phillips D, Norman R, Davies M . The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2009; 25(2):544-51. DOI: 10.1093/humrep/dep399. View

20.

Thomson R, Buckley J, Moran L, Noakes M, Clifton P, Norman R . The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Hum Reprod. 2009; 24(8):1976-81. DOI: 10.1093/humrep/dep101. View